NDRA (ENDRA Life Sciences) Accounts Payable: $0.46 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NDRA ENDRA Life Sciences Inc NDRA
25 GF Score
Price $5.45
! 2 Warning Signs
View Full Analysis

What is ENDRA Life Sciences Accounts Payable?

ENDRA Life Sciences NDRA +1.93% 25 Accounts Payable is $0.46 Mil as of Mar. 2026. GuruFocus rates NDRA with a GF Score™ of 25/100. The stock has 2 warning signs investors should review.

ENDRA Life Sciences's Accounts Payable for the quarter that ended in Mar. 2026 was $0.46 Mil.

ENDRA Life Sciences's quarterly Accounts Payable increased from Sep. 2025 ($0.25 Mil) to Dec. 2025 ($0.38 Mil) and increased from Dec. 2025 ($0.38 Mil) to Mar. 2026 ($0.46 Mil).

ENDRA Life Sciences's annual Accounts Payable declined from Dec. 2023 ($0.36 Mil) to Dec. 2024 ($0.27 Mil) but then increased from Dec. 2024 ($0.27 Mil) to Dec. 2025 ($0.38 Mil).

ENDRA Life Sciences Accounts Payable Related Terms

ENDRA Life Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for ENDRA Life Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENDRA Life Sciences Accounts Payable Chart

ENDRA Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 0.61 0.36 0.27 0.38

ENDRA Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.28 0.25 0.38 0.46
NDRA
25GF Score
ENDRA Life Sciences Inc NDRA
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENDRA Life Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.46 Mil mean?
ENDRA Life Sciences (NDRA) has a Accounts Payable of $0.46 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on ENDRA Life Sciences and its competitors.
Is ENDRA Life Sciences' Accounts Payable too high?
ENDRA Life Sciences' current Accounts Payable is $0.46 Mil. Overall, ENDRA Life Sciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENDRA Life Sciences' Accounts Payable compare to BIAF and ADVB?
ENDRA Life Sciences' Accounts Payable of $0.46 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on ENDRA Life Sciences and its competitors. ENDRA Life Sciences's current Accounts Payable is $0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENDRA Life Sciences stock overvalued right now?
ENDRA Life Sciences (NDRA) has a current Accounts Payable of $0.46 Mil. The current Accounts Payable is $0.46 Mil. ENDRA Life Sciences' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current Accounts Payable is $0.46 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
25GF Score

Get the complete analysis for NDRA

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.45
Price